PrimXMAD:PRM 76 Receivables Turnover is 2.32 as of Dec. 2025. GuruFocus rates XMAD:PRM with a GF Score™ of 76/100 and a GF Value™ of €7.44 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 812 Medical Devices & Instruments companies, Prim ranks worse than 63.3% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Prim's Revenue for the
six
months ended in Dec. 2025 was €124.8 Mil. Prim's average Accounts Receivable for the
six
months ended in Dec. 2025 was €53.8 Mil.
Hence, Prim's Receivables Turnover for the
six
months ended in Dec. 2025 was 2.32.
Prim (XMAD:PRM) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Prim Receivables Turnover Related Terms
Prim Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Prim's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XMAD:PRM vs ISRG, BDX, MDLN: Receivables Turnover Comparison
For the Medical Instruments & Supplies subindustry, Prim's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prim Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Prim's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Prim's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Prim (XMAD:PRM) has a Receivables Turnover of 2.32 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Prim and its competitors. According to the industry distribution chart, Prim ranks #514 out of 812 companies in the Medical Devices & Instruments industry, placing it in the top 63.3%.
Is Prim's Receivables Turnover too high?
Prim's current Receivables Turnover is 2.32. The Medical Devices & Instruments industry median Receivables Turnover is 5.53. Prim's value of 2.32 is 58% below this industry median. Based on the distribution chart, Prim ranks #514 out of 812 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Prim has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Prim's Receivables Turnover compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Prim ranks #514 out of 812 companies for Receivables Turnover. This places Prim in the lower half of its industry. The industry median Receivables Turnover is 5.53. Prim's value of 2.32 is 58% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.53, based on 812 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Prim's current Receivables Turnover of 2.32 is 58% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Prim and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Prim's current Receivables Turnover is 2.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prim stock overvalued right now?
Based on GuruFocus' analysis, Prim (XMAD:PRM) is currently considered Significantly Overvalued. The stock's GF Value™ is €7.44, compared to a current price of €13.40 — trading 80.1% above its estimated fair value. The current Receivables Turnover is 2.32 and 58% below the Medical Devices & Instruments industry median of 5.53. Prim's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Prim (XMAD:PRM), the current Receivables Turnover is 2.32 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Prim (XMAD:PRM) Overvalued in 2026?
Based on GuruFocus' analysis, Prim stock appears to be overvalued.
The current stock price of €13.40 is trading 80.1% above its estimated GF Value™ of €7.44.
GuruFocus considers Prim to be Significantly Overvalued.
Key valuation signals for XMAD:PRM:
Receivables Turnover: 2.32
GF Value™: €7.44 vs. price of €13.40 (80.1% above fair value)
Industry Position: 58% below the Medical Devices & Instruments median (#514 of 812)
No single metric tells the full story. See the XMAD:PRM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Prim SA is engaged in the provision of hospital supplies. The company is in a hospital and orthopedic supplies and materials for physiotherapy, thalassotherapy, thermal therapy, rehabilitation, geriatrics, as well as daily living aids. Prim work across a division of healthcare units such as Operating Theatres; Pain Management Centres; Plastic Surgery; Endosurgery and Cardiovascular.
76GF Score
Get the complete analysis for XMAD:PRM
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XMAD:PRM has been successfully added to your 
